Molecular Diagnostics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Molecular 
Diagnostics Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  IM A R C  G ro u p ,  t i t l e d  " M o l e c u l a r  D i ag n o s t i c s  Ma r k e t :  
G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  Gr o w th ,  O p p o r t u n i t y  a n d  F o r e c as t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  m o l e c u l a r  d i a gn o s t i c s  m a r ke t  s i ze  r e a ch e d  U S $  1 9 .7  B i l l i o n  i n  2 0 2 3 .
Mo l e c u l a r  d i a g n os t i c s  i s  a  s p e c i a l i z e d  f i e l d  w i t h i n  m e d i c a l  t e s t i n g  t h a t  i n v o l ve s  t he  
Report an a l y s i s  o f  b i o l o g i c a l  m a r k e r s  i n  an  i nd i v i d u a l ' s  g e n e t i c  c o d e .  I t  e m p l oy s  v a r i ou s  
t ec h n i q u es  t o  d e te c t  s p ec i f i c  se q u e n ce s  i n  de o x y r i b o n u c l e i c  a c i d  ( D N A )  a n d  r i b o n u c l e i c  
ac i d  ( R N A )  t h a t  m ay  b e  re l a t e d  t o  d i s ea s e s ,  c o n d i t i on s ,  o r  g e n e t i c  p r ed i s p o s i t i o n s .  
Highlight and Mo l e c u l a r  d i ag n o s t i c s  i de n t i f i e s  t he s e  m a r k e r s  a n d  e na b l e s  p r e c i se  d i a g no s i s ,  e a r l y  
de t e c t i o n ,  an d  p e r so n a l i z e d  t r e a t me n t  p l a n s  t a i l o r ed  t o  a  p a t i e n t ' s  g en e t i c  ma k e u p .  I t  
Description i s  p r i m a r i l y  us e d  i n  t h e  m e d i c a l  f i e l d  t o  d i a gn o s e  a n d  mo n i t o r  d i s e a s es  l i k e  ca n c e r ,  i n fe c t i o u s  d i s e a se s ,  a n d  g e n e t i c  d i s o r de r s .  I t  p l a ys  a  c r u c i a l  r o l e  i n  p e rs o n a l i z e d  
me d i c i n e ,  w h e r e  t re a t me n t s  c a n  b e  a d j u s t e d  a n d  t a r g e t e d  ba s e d  o n  th e  un i q u e  g e n e t i c  
p r o f i l e  o f  a  p a t i e n t .
R eq u e s t  f o r  a  P D F  sa m p le  o f  th i s  r ep o r t :  
h t t p s : / /w w w . i ma r c g r o u p . co m / mo l e c u l a r - d i a g no s t i c s - ma r k e t / r e qu e s t sa m p l e
Report Description
G l ob a l  M o l ec u l a r  D i a gnost i cs  M arke t  T re nds :
The  g r ow ing  p r ev a lenc e  o f  i n f e c t i o us  d i s ease s  an d  ch r on i c  cond i t i ons ,  suc h  as  c anc e r ,  d r i v i ng  t he  need  f o r  m or e  
accu r a t e  an d  t im e ly  d iagnos es  i s  one  o f  t he  m a jo r  f ac t o r s  con t r i bu t i ng  t o  t he  m ar k e t  g r ow t h .  I n  l i n e  w i t h  t h i s ,  r ap id  
t ech no log i ca l  ad vance m en t s  i n  geno m ics  and  p r o t eom ic s  p av ing  t he  way  f o r  m or e  s oph is t i ca t e d  and  p r ec i se  d iag nos t i c  
m e t h ods ,  enhan c ing  t he  e f f ec t i vene ss  o f  pe r so na l i ze d  m ed ic ine  i s  a l so  p r ov id ing  a  t h r u s t  t o  t he  m a r ke t  g r o w t h .  
Add i t io na l l y ,  t he  g r ow ing  e m ph as i s  o n  ea r l y  de t ec t i on  an d  p r e ven t i on  o f  d i s eases  i s  f avo r i ng  t h e  m ar ke t  g r o w t h .  
I n  a dd i t i o n  t o  t h i s ,  t he  r i se  o f  p a t i e n t - cen t e r e d  he a l t h ca r e  and  t he  i nc r eas in g  r e cogn i t i on  o f  t h e  im p o r t an ce  o f  t a r ge t e d  
t he r a py  a r e  s t r eng t hen ing  t he  m ar k e t  g r o w t h .  I n  con f l uenc e  w i t h  t h i s ,  t he  s udde n  sh i f t  t owar ds  em br a c ing  b io i n f o r m a t i cs  
and  d a t a  a na l y t i c s  i n  d iagno s t i cs  a nd  t he  de ve lop m en t  o f  po r t ab le ,  u se r - f r i en d l y  dev ic es  m a k ing  m o lecu l a r  d iagn os t i cs  
m or e  acce ss ib le  a r e  c r ea t i ng  a  po s i t i ve  ou t l ook  f o r  t he  m ar ke t  g r ow t h .  Fu r t he r m or e ,  t he  a dve n t  o f  r eg u la t o r y  supp o r t  an d  
f avo r ab le  r e im bur se m en t  po l i c i es  f ocuse d  on  p r o m o t i ng  m o lecu la r  d ia gnos t i cs  i s  pos i t i ve l y  im p ac t i ng  t he  m ar ke t  g r ow t h .
Look i ng  f o rw ar d ,  t h e  mar ke t  va l ue  i s  p ro j e c t ed  t o  r each  US$  3 3 . 7  B i l l i on  b y  2 032 ,  ex pand i ng  a t  a  CAG R o f  6 . 1%  
dur i ng  20 24 - 2 032 .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / m ol ec u l a r - d i agn ost i cs - m arke t
Breakup by Product:
• Reagents and K i ts
• Instruments
• Software and Services
 
Breakup by Technology:
• Polymerase Chain React ions (PCR)
Report • Hybridizat ion
• DNA Sequencing
Segmentation
• Microarray
• Isothermal  Nucleic  Acid Ampl ifi cat ion 
Technology ( INAAT)
• Others
Breakup by Application:
• Infect ious Diseases Diagnost ics
• Oncology
• Genetic  Test ing
• Blood Screening
• Others
Breakup by End Users:
• Hospitals
Report • Laborator ies
Segmentation • Others
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Lat in America
• Middle  East and Afr ica
• Abbott Laborator ies
• Agi lent Technologies Inc.
• Becton Dickinson and Company
• Biomerieux SA
Competitive • Danaher Corporation
• Diasorin Molecular LLC (DiaSorin)
Landscape • F.  Hoff mann-La Roche AG (Roche Holding 
with Key AG)
• Hologic Inc.
Players • I l lumina Inc.
• Myriad Genetics Inc.
• Qiagen
• Quidel Corporat ion
• Thermo Fisher Scientifi c
How has the global molecular diagnostics market 
performed so far, and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in 
the global molecular diagnostics market?
What is the impact of each driver, restraint, and 
opportunity on the global molecular diagnostics 
Key market?
Questions What are the key regional markets?
Answered in 
Which countries represent the most attractive 
molecular diagnostics market?
the Report
What is the breakup of the market based on the 
product?
Which is the most attractive product in the molecular 
diagnostics market?
What is the breakup of the market based on the 
technology?
Which is the most attractive technology in the 
molecular diagnostics market?
What is the breakup of the market based on the 
application?
Key Which is the most attractive application in the molecular diagnostics market?
Questions 
What is the breakup of the market based on end users?
Answered in 
Which are the most attractive end users in the 
the Report molecular diagnostics market?
What is the competitive structure of the global 
molecular diagnostics market?
Who are the key players/companies in the global 
molecular diagnostics market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  M o l e c u l a r  D i a g n o s t i c s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     R e a g e n t s  a n d  K i t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     I n s t r u m e n t s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     S o f t w a r e  a n d  S e r v i c e s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T e c h n o l o g y
       
    7 . 1     P o l y m e r a s e  C h a i n  R e a c t i o n s  ( P C R )
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     H y b r i d i z a t i o n
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     D N A  S e q u e n c i n g
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     M i c r o a r r a y
        7 . 4 . 1  M a r k e t  T r e n d s
Table of         7 . 4 . 2  M a r k e t  F o r e c a s t    7 . 5     I s o t h e r m a l  N u c l e i c  A c i d  A m p l i f i c a t i o n  T e c h n o l o g y  ( I N A A T )
        7 . 5 . 1  M a r k e t  T r e n d s
Contents         7 . 5 . 2  M a r k e t  F o r e c a s t    7 . 6     O t h e r s
        7 . 6 . 1  M a r k e t  T r e n d s
        7 . 6 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     I n f e c t i o u s  D i s e a s e s  D i a g n o s t i c s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     O n c o l o g y
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     G e n e t i c  T e s t i n g
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /m o l ec u l a r-d i a gn o s t i c s -m a rke t / t o
c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: